Wintech Nano
688757
CHANGFU CO.,LTD
871396
DIER CHEMICAL
831304
4
CHENGUANG MEDICAL
430300
5
TLC
873576
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 3.79%105.62B | 17.93%85.87B | 17.19%56.37B | 8.09%24.29B | -6.89%101.76B | -9.79%72.82B | -12.85%48.1B | -24.20%22.47B | -12.11%109.29B | -17.48%80.72B |
Operating revenue | 3.79%105.62B | 17.93%85.87B | 17.19%56.37B | 8.09%24.29B | -6.89%101.76B | -9.79%72.82B | -12.85%48.1B | -24.20%22.47B | -12.11%109.29B | -17.48%80.72B |
Total operating cost | 3.88%105.1B | 18.33%85.3B | 17.77%55.81B | 9.06%24.16B | -6.37%101.18B | -8.76%72.09B | -12.32%47.39B | -23.88%22.15B | -12.58%108.06B | -18.54%79.02B |
Operating cost | 4.29%100.08B | 19.39%81.69B | 18.59%53.46B | 10.06%23.04B | -7.02%95.96B | -9.52%68.42B | -12.95%45.08B | -24.97%20.93B | -13.08%103.2B | -19.27%75.62B |
Operating tax surcharges | 20.17%329.6M | 20.40%229.06M | 24.58%152.87M | 8.51%69.13M | 6.26%274.27M | 2.11%190.25M | -6.96%122.7M | 1.30%63.71M | 15.90%258.11M | 19.24%186.32M |
Operating expense | -7.03%1B | -6.12%719.33M | -6.05%486.35M | 4.51%250.95M | 0.86%1.08B | -3.91%766.25M | -2.86%517.65M | 1.00%240.12M | 9.58%1.07B | 14.85%797.4M |
Administration expense | -1.61%3.33B | -3.61%2.3B | -5.90%1.5B | -5.14%693.84M | -0.31%3.38B | -2.74%2.38B | 0.48%1.6B | -0.48%731.41M | 8.56%3.39B | 15.13%2.45B |
Financial expense | -4.52%247.16M | 31.30%249.25M | 215.93%126.61M | -46.91%84.59M | 613.34%258.86M | 232.39%189.83M | 184.24%40.08M | 9.12%159.33M | -112.62%-50.43M | -155.65%-143.38M |
-Interest expense (Financial expense) | -23.01%400M | -22.57%311.3M | -16.53%210.85M | -18.45%106.93M | 8.23%519.57M | 18.61%402.05M | 15.90%252.62M | 23.32%131.12M | 15.21%480.05M | 5.70%338.97M |
-Interest Income (Financial expense) | 49.13%-141.36M | 47.28%-109.28M | 36.34%-88.74M | 27.16%-44.64M | -53.58%-277.91M | -72.76%-207.28M | -78.49%-139.4M | -78.12%-61.28M | -30.80%-180.95M | -7.63%-119.98M |
Research and development | -48.26%120.66M | -12.71%124.34M | 198.70%77.29M | -8.95%26.49M | 18.89%233.19M | 34.05%142.45M | -47.10%25.88M | 15.93%29.1M | 14.30%196.14M | 9.97%106.26M |
Credit Impairment Loss | -248.08%-85.14M | -33.58%-113.44M | -119.34%-100.11M | -31.22%-50.6M | 12.29%-24.46M | 1.73%-84.92M | 19.67%-45.64M | 29.37%-38.56M | 77.23%-27.89M | -848.41%-86.41M |
Asset Impairment Loss | 92.16%-25.67M | 101.07%5.04K | 100.98%5.04K | -52.27%5.04K | -181.98%-327.43M | -21,151.76%-472.76K | ---515.86K | 117.12%10.57K | 48.88%-116.12M | 100.03%2.25K |
Other net revenue | -9.40%4.42B | -10.37%3.01B | -11.39%1.88B | -0.94%889.5M | 21.56%4.88B | 19.51%3.36B | 13.66%2.12B | 37.10%897.91M | -2.83%4.02B | -9.68%2.81B |
Fair value change income | -8.36%244.56M | 177.02%38.34M | 53.24%-12.76M | -81.27%-14.95M | 354.32%266.88M | 46.78%-49.77M | 64.93%-27.29M | 86.24%-8.25M | -201.71%-104.94M | -209.39%-93.53M |
Invest income | -12.46%2.04B | -12.35%1.47B | -10.37%975.05M | -0.94%478.27M | -9.81%2.33B | -13.74%1.67B | -18.10%1.09B | -11.47%482.83M | 2.85%2.58B | 11.55%1.94B |
-Including: Investment income associates | -17.22%1.88B | -10.10%1.46B | -5.50%976.89M | -0.94%478.27M | -4.92%2.27B | -9.94%1.62B | -12.42%1.03B | -11.47%482.83M | -0.98%2.39B | 3.84%1.8B |
Asset deal income | -63.26%68.43M | -71.99%41.36M | -80.54%12.07M | -258.56%-851.87K | -4.92%186.27M | 1,529.95%147.64M | 847.37%61.99M | -65.85%537.24K | 67.46%195.91M | -91.56%9.06M |
Other revenue | -11.00%2.18B | -5.72%1.58B | -3.80%1.01B | 3.53%477.63M | 64.73%2.45B | 60.65%1.68B | 56.65%1.05B | 107.27%461.34M | -21.28%1.49B | -13.02%1.04B |
Adjusted Items effecting operating profit | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- |
Operating profit | -9.59%4.94B | -12.34%3.58B | -13.94%2.44B | -16.31%1.02B | 4.12%5.46B | -9.54%4.09B | -5.91%2.84B | 1.63%1.21B | 7.82%5.25B | 14.97%4.52B |
Add:Non operating Income | -22.52%79.98M | -23.44%42.75M | -26.40%33.68M | -62.15%7.7M | 55.50%103.23M | 40.05%55.84M | 82.77%45.76M | 91.08%20.35M | -15.79%66.38M | -42.95%39.87M |
Less:Non operating expense | -97.08%1.94M | -169.13%-19.03M | -173.59%-21.43M | -15.69%5.09M | -6.25%66.4M | -2.40%27.52M | -26.58%29.12M | 309.10%6.04M | -66.88%70.82M | -85.21%28.2M |
Total profit | -8.78%5.02B | -11.44%3.64B | -12.51%2.5B | -17.07%1.02B | 4.91%5.5B | -9.15%4.11B | -4.89%2.85B | 1.68%1.23B | 10.80%5.24B | 18.93%4.53B |
Less:Income tax cost | -20.56%838.2M | -26.67%605.65M | -23.43%413.59M | -23.00%175.63M | 9.05%1.06B | 9.17%825.92M | -2.37%540.14M | 9.08%228.08M | 21.01%967.54M | 31.52%756.56M |
Net profit | -5.98%4.18B | -7.62%3.04B | -9.97%2.08B | -15.72%842.3M | 3.97%4.45B | -12.83%3.29B | -5.47%2.31B | 0.13%999.42M | 8.72%4.28B | 16.69%3.77B |
Net profit from continuing operation | -5.98%4.18B | -7.62%3.04B | -9.97%2.08B | -15.72%842.3M | 3.97%4.45B | -12.83%3.29B | -5.47%2.31B | 0.13%999.42M | 8.72%4.28B | 16.69%3.77B |
Less:Minority Profit | 13.49%262M | 58.14%212.3M | 7.88%139.1M | -8.48%39.56M | 17.33%230.85M | -31.10%134.25M | 7.10%128.94M | 178.34%43.23M | -10.29%196.75M | 27.44%194.84M |
Net profit of parent company owners | -7.05%3.92B | -10.41%2.83B | -11.02%1.95B | -16.05%802.73M | 3.32%4.21B | -11.83%3.15B | -6.11%2.19B | -2.69%956.19M | 9.85%4.08B | 16.15%3.58B |
Earning per share | ||||||||||
Basic earning per share | -7.24%0.5396 | -9.53%0.3891 | -11.17%0.268 | -15.38%0.11 | 4.83%0.5817 | -11.01%0.4301 | -2.68%0.3017 | 0.00%0.13 | 10.98%0.5549 | 15.07%0.4833 |
Diluted earning per share | -7.33%0.5386 | -9.72%0.3883 | -11.37%0.2674 | -15.38%0.11 | 4.74%0.5812 | -11.01%0.4301 | -2.68%0.3017 | 0.00%0.13 | 10.98%0.5549 | 15.07%0.4833 |
Other composite income | -170.11%-104.66M | -144.49%-124.19M | -222.75%-211.51M | -122.80%-26.34M | 9.93%149.29M | 1,016.53%279.1M | 707.37%172.31M | -264.48%-11.82M | 171.21%135.8M | 71.82%-30.45M |
Other composite income of parent company owners | -154.95%-92.56M | -145.28%-123.71M | -222.21%-210.16M | -180.94%-26.71M | 44.46%168.44M | 753.96%273.23M | 9,465.43%171.96M | -298.42%-9.51M | 161.38%116.6M | 62.47%-41.78M |
Other composite income of minority owners | 36.85%-12.1M | -108.18%-480.12K | -491.53%-1.35M | 116.02%370.74K | -199.79%-19.16M | -48.17%5.87M | 101.30%345.75K | -196.60%-2.31M | 2,722.36%19.2M | 249.03%11.33M |
Total composite income | -11.32%4.07B | -18.33%2.91B | -24.71%1.87B | -17.38%815.96M | 4.15%4.59B | -4.66%3.57B | 2.76%2.49B | -1.53%987.6M | 17.89%4.41B | 19.75%3.74B |
Total composite income of parent company owners | -12.73%3.83B | -21.17%2.7B | -26.42%1.73B | -18.03%776.03M | 4.47%4.38B | -3.06%3.43B | 1.35%2.36B | -3.89%946.68M | 19.08%4.2B | 19.10%3.54B |
Total composite income of minority owners | 18.05%249.9M | 51.17%211.82M | 6.54%137.74M | -2.40%39.93M | -1.98%211.69M | -32.04%140.12M | 37.74%129.28M | 128.23%40.92M | -1.20%215.95M | 32.05%206.17M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.